Longevity Latest • Issue 02
Longevity Latest
The Evidence-Based Edge on Living Longer and Better
👋 Welcome to Longevity Latest
Welcome back. This week we’re tackling the question that dominated our inbox after Issue 01: should you be spending £150 a month on NAD+ precursors, or is there a cheaper alternative hiding in the vitamin aisle?
We put NMN, NR, and plain niacin head-to-head. We grade each one. We let the evidence talk. The answer involves a 90-year-old vitamin and some uncomfortable truths about marketing.
In this issue:
🔬 Top 3 — NMN, NR, and niacin graded on our A–F scale
💡 Spotlight — Berberine: the over-the-counter AMPK activator
🚨 Hype Check — That viral “biological age reversal” study
🥦 Superfood — Walnuts and the omega-3 mortality data
🔍 Deep Dive — Sirtuins and NAD+: why “more” isn’t always better
⚙️ Biohacking — Time-restricted eating: what the largest trial found
🔬 Top 3 Interventions Under the Microscope
1. Nicotinamide Mononucleotide (NMN)
Evidence Grade: D Pre-clinical only
What it is. NMN is a direct precursor to NAD+, the coenzyme essential for energy metabolism, DNA repair, and sirtuin activation. It’s marketed as the premium NAD+ booster at £100–£200/month for 250–500 mg/day.
Human evidence. A 2024 meta-analysis (Zhang et al., Crit Rev Food Sci Nutr; 12 RCTs, n=513; PMID: 39116016) found NMN reliably raises blood NAD+ but clinically relevant outcomes — fasting glucose, insulin resistance, lipid profiles — were not significantly different from placebo. Five of twelve studies had high risk of bias. A 2025 systematic review (J Cachexia Sarcopenia Muscle) found no significant improvements in muscle mass, grip strength, or gait speed. A January 2026 head-to-head trial (Christen et al., Nature Metabolism) showed NMN and NR both doubled circulating NAD+ over 14 days, with neither demonstrating clinical superiority.
Cautions. Well-tolerated at 250–1,200 mg/day in trials up to 12 weeks. No long-term safety data. Quality control is poor — independent testing shows significant potency variability between brands.
Takeaway. NMN raises a biomarker. That’s not the same as improving health. No published RCT has shown meaningful clinical benefits in healthy adults. At £150/month, you’re paying for a surrogate endpoint change. Evidence Grade D: pre-clinical promise, insufficient human outcomes.
2. Nicotinamide Riboside (NR)
Evidence Grade: B Promising human data
What it is. NR enters cells via the NRK pathway and converts to NMN intracellularly before becoming NAD+. Available as Niagen® (ChromaDex) at £40–£70/month. Unlike NMN, NR has a more established safety record from larger clinical trials.
Human evidence. The NICE trial (Nature Communications, 2024; n=90) showed NR at 1,000 mg/day meaningfully improved 6-minute walk distance in peripheral artery disease — one of the few NAD+ precursor trials with a functional clinical outcome. NR-SAFE (Nature Communications, 2023; n=20) demonstrated safety at 3,000 mg/day in Parkinson’s patients with significant NAD+ augmentation. A small MCI trial (Orr et al., GeroScience, 2024; n=20; PMID: 37994989) found modest epigenetic age reductions, though cognition was unchanged.
Cautions. Well-tolerated up to 3,000 mg/day. No flushing. ChromaDex funds much of the NR research — always worth noting when evaluating results.
Takeaway. NR has the strongest clinical trial record of any NAD+ precursor. The NICE trial’s functional outcome data puts it a clear step ahead of NMN, at roughly half the price. Evidence Grade B: promising human data from multiple trials, though most are small or disease-specific.
3. Niacin (Nicotinic Acid / Vitamin B3)
Evidence Grade: B- Established metabolic data, longevity data lacking
What it is. Plain niacin — the original vitamin B3 — is the oldest and cheapest NAD+ precursor. It boosts NAD+ via the Preiss-Handler pathway and has been used clinically for six decades. Cost: approximately £0.03/day for 500 mg.
Human evidence. Pirinen et al. (Cell Metabolism, 2020; n=30; PMID: 32386566) showed niacin at 750–1,000 mg/day increased blood NAD+ up to 8-fold, with improvements in muscle strength and mitochondrial biogenesis. Liver fat decreased up to 50% in patients. Decades of cardiovascular data confirm it raises HDL and lowers triglycerides. However, a 2017 Cochrane review found niacin did not reduce overall mortality when added to statin therapy. The Christen et al. 2026 trial found NR and NMN work via gut-bacteria-mediated conversion to nicotinic acid — the expensive precursors may ultimately use the same pathway as plain niacin.
Cautions. Flushing (warmth, redness, itching) is the major barrier. Start at 100 mg and titrate up. Extended-release formulations reduce flushing but carry liver toxicity risk. Nicotinamide (niacinamide) avoids the flush but inhibits sirtuins at high concentrations — potentially counterproductive for longevity.
Takeaway. The unglamorous workhorse. Longest clinical track record, strongest metabolic data, lowest cost. Evidence Grade B-: robust metabolic and cardiovascular data, but direct longevity evidence is lacking — keeping it a notch below NR’s functional outcome results.
💡 Spotlight Treatment: Berberine
Berberine is a plant alkaloid from barberry and goldenseal, used in traditional Chinese medicine for centuries to treat gastrointestinal infections. In the longevity community, it has gained traction as a natural metformin alternative — available without prescription, activating many of the same pathways, and at a fraction of the cost.
✅ The Case For
Berberine activates AMPK through multiple routes without directly inhibiting mitochondrial Complex I — theoretically more exercise-compatible than metformin. A meta-analysis (Guo et al., Oxid Med Cell Longev, 2021; PMID: 34956436; 20 RCTs) found berberine at 900–2,400 mg/day significantly reduced fasting glucose, HbA1c, and triglycerides in type 2 diabetes, with effects comparable to metformin. It also lowers LDL cholesterol. Over-the-counter at £10–20/month.
❌ The Case Against
Oral bioavailability under 1% versus metformin’s 50–60%. Only 34 completed clinical trials versus 1,600+ for metformin. No human longevity trials. Supplement quality is inconsistent — one study found 60% of products failed potency standards.
Bottom Line
🚨 Hype Check: That Viral “Age Reversal” Study
🥦 Superfood Spotlight: Walnuts
Walnuts are the highest tree nut source of alpha-linolenic acid (ALA), a plant-based omega-3, and among the richest food sources of polyphenols. They feature prominently in Mediterranean diet patterns and are a daily staple in several Blue Zone populations, particularly Sardinia and Ikaria, where nut consumption is a consistent dietary marker among the longest-lived cohorts.
The Nurses’ Health Study (Guasch-Ferré et al., Nutrients, 2019; n>118,000) found consuming walnuts five or more times weekly was associated with significantly lower all-cause mortality. A 2021 RCT meta-analysis confirmed walnut consumption improves endothelial function and lowers LDL. Their ellagitannins support gut microbiome diversity — itself an emerging longevity biomarker.
Practical serving: 30g daily (7–8 halves). Add to porridge or salads. Store in the fridge — polyunsaturated fats oxidise quickly. Calorie-dense (~185 kcal/30g). Tree nut allergy is a contraindication.
🔍 Deep Dive: Sirtuins and NAD+ Metabolism
⚙️ Biohacking Corner: Time-Restricted Eating
A 2022 NEJM trial (Liu et al.; n=139; 12 months; PMID: 35443107) compared calorie restriction alone versus restriction within a 16:8 window. Both groups lost similar weight with comparable metabolic improvements. The time restriction conferred no additional benefit. This was the study that quieted much of the intermittent fasting community — and it deserves a closer look.
However, Sutton et al. (Cell Metabolism, 2018; crossover, n=8) found that even without calorie reduction, a 6-hour window improved insulin sensitivity and blood pressure in men with prediabetes. Timing may matter most for those with existing metabolic dysfunction.
Three evidence-based takeaways:
1. Metabolically healthy? A strict 16:8 window is unlikely to beat calorie control alone. Don’t force it.
2. Insulin resistant? Time-restricted eating may offer genuine benefits beyond calorie restriction.
3. Either way: A consistent 12-hour overnight fast (7pm–7am) is well-supported. Avoid eating within 2–3 hours of bedtime.
📊 Reader Pulse
👋 See You Next Week
Next week in Issue 03: We’re grading rapamycin, spermidine, and quercetin — three compounds targeting autophagy, the cellular recycling system that declines with age. Quercetin goes under the Spotlight as a potential senolytic. And the Hype Check tackles a popular “telomere lengthening” supplement that costs £100 per bottle. You’ll want to read that one before you buy it.
Know someone tired of longevity hype? Forward this issue. Every subscriber helps us stay independent.
Stay curious and stay healthy!
— The Longevity Latest Team
Medical Disclaimer
Longevity Latest is for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting any new supplement, medication, or health protocol. Personal notes reflect individual experience and are not presented as evidence. Interventions graded in this newsletter reflect our assessment of the published evidence and do not constitute personal recommendations.
© 2026 Longevity Latest Newsletter
The Evidence-Based Edge on Living Longer and Better